Clinical Trial Update: Treatment of Atraumatic Bone Marrow Edema With Denosumab and Teriparatide vs Placebo [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating denosumab plus teriparatide versus placebo for atraumatic bone marrow edema syndrome and high-turnover bone disease has been suspende…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Edema Syndrome
• High-turnover Bone Disease

Drugs mentioned

• Denosumab (denosumab)
• Teriparatide (Teriparatide)

Snippet

Sponsor: Medical University of Vienna | Conditions: Bone Marrow Oedema Syndrome, High Turnover Bone Disease | Phase 4 | Status: SUSPENDED